About PHI
PHI is a publicly listed company based in Boston (United States) founded in 2004, and was acquired by Altium in March 2023. Holographic imaging devices are manufactured by PHI in Boston. It operates on a Direct-to-Consumer (D2C) and Professional Services model. Its website phiab.com draws about 13 thousand monthly visits. PHI offers products and services including HoloMonitor and App Suite. Its focus areas include Medical Devices and Imaging Systems. Its legal entity is Phase Holographic Imaging PHI AB.
Company details
Non-invasive live cell imaging systems are developed and offered by Phase Holographic Imaging PHI AB. The company focuses on providing innovative tools like HoloMonitor for real-time cell monitoring in incubators. Solutions cater to sectors such as cancer research, stem cell studies, and drug discovery. Quantitative phase imaging technology is utilized to ensure cell-friendly analysis without labels or stains. Applications include cell morphology, migration, and proliferation analysis for researchers globally.
- Annual Revenue$1.73 M (USD)58.38as on Apr 30, 2025
- Net Profit-$1.82 M (USD)13.16as on Apr 30, 2025
- EBITDA-$1.25 M (USD)10.21as on Apr 30, 2025
- Latest Funding Round$504.84K (USD), Post-IPO
Oct 2024
- InvestorsEuropean Union
& 2 more
- Acquired byAltium
(Mar 2023)
Products & Services of PHI
PHI offers a comprehensive portfolio of products and services, including HoloMonitor and App Suite.
A system for non-invasive live cell analysis.
Software for analyzing live cell imaging data.
Apps and channels of PHI
its YouTube channel Phase Holographic Imaging has 398 subscribers and 30 videos.
Videos from PHI
The most watched videos on PHI's YouTube channel, Phase Holographic Imaging (398 subscribers). Click a video to play it here.
More on Phase Holographic Imaging.
Funding Insights of PHI
- Total Rounds 3
- Last Round Post-IPO — $504,837
- First Round $280,970
(Apr 2017)
- Investors Count 2
All 3 funding rounds of PHI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | $504,837 | Post-IPO | – | – | – |
| May 2024 | $654,916 | Debt – Conventional | – | – | |
| Apr 2017 | $280,970 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in PHI
PHI has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Union, Bizcap and Altium.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers flexible loans and credit to small and medium-sized enterprises in Sweden. | 2021 | bizcap.se | Stockholm, Sweden | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Altium S.A. is recognized as a provider of laboratory solutions worldwide. | altium.net | Geneva, Switzerland |
Investor details for PHI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of PHI
PHI is a publicly listed company on the NGM with ticker symbol PHI in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date21 Jul 2023
- Listed onFRA: L5W
- Listed entityPHASE HOLOGRAPHIC IMAGING PHI AB
- Exchange sectorHealth technology
- ISINSE0005504636
- Share price0.53 SEK (-7.02% on the day) · 2026-01-13
- Market capitalisation33,417,442.00 SEK
- EPS (diluted, trailing year)-0.42 SEK
- Volume (last session)176,671
- Analyst consensusNeutral
Financials of PHI
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | 16.6M SEK | -17.5M SEK | -12.1M SEK |
| 2023 | 10.5M SEK | -20.2M SEK | -13.4M SEK |
| 2022 | 9.9M SEK | -23.2M SEK | -16.9M SEK |
| 2021 | 8.2M SEK | -25.4M SEK | -19.4M SEK |
| 2020 | 3.6M SEK | -23.5M SEK | -24.7M SEK |
Detailed financial statements for PHI
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of PHI
5 dated milestones of PHI across 20 years, from founding to its latest funding, stage changes and deals.
- Founded PHI is founded.
- Funding First funding round of $281K.
- Exit Acquired by Altium.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $505K.
Web traffic of PHI
The website of PHI (phiab.com) receives about 13K visits a month.
- Monthly visits13K
▲ 0.5% vs previous month
Websites whose visitors overlap most with PHI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| phioptics.com | 100% | 3.4K | #5,648,314 | View details | |
globalsupply.com | globalsupply.com | 79% | #2,476,852 | – | |
nationalpetroleum.net | nationalpetroleum.net | 75% | #3,403,597 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as PHI (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Phi
Complete news archive for PHI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PHI
PHI was founded in 2004 and raised its 1st funding round 13 years after it was founded.
PHI is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Annual revenue of PHI is $1.73M as on Apr 30, 2025.
Non-invasive live cell imaging systems are developed and offered by Phase Holographic Imaging PHI AB. The company focuses on providing innovative tools like HoloMonitor for real-time cell monitoring in incubators. Solutions cater to sectors such as cancer research, stem cell studies, and drug discovery. Quantitative phase imaging technology is utilized to ensure cell-friendly analysis without labels or stains. Applications include cell morphology, migration, and proliferation analysis for researchers globally.
PHI offers HoloMonitor and App Suite.
Yes, PHI is publicly traded on NGM under the ticker symbol PHI.
PHI has 3 investors. Key investors include European Union, Bizcap, and Altium.
PHI operates through Phase Holographic Imaging Phi Ab.
Yes. PHI was acquired by Altium in March 2023.